LIONHEART-HCM: BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Aug 10, 2026 - P3 | N=210 | Not yet recruiting | Sponsor: Braveheart Bio, Inc.
New P3 trial • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|